Diagnostic.ly Expands Platform with AI Collection and Automated Treatment Tools

Diagnostic.ly has introduced new at-home diagnostics capabilities that extend its platform from test ordering through treatment and follow-up testing according to a press release. The expansion enables healthcare organizations to automate actions based on diagnostic results and verify treatment efficacy through repeat testing.

At the core of the launch is a patent-pending AI specimen collection observation system that detects failed specimen collections as they occur. The system can reduce the cost of failed collections by up to 90 percent and accelerate result turnaround by preventing the need for repeat shipments.

The platform now supports automated Test and Treat and Treat and Prove workflows, allowing healthcare providers to generate recommendations and schedule validation tests automatically. Patients performing home collections receive real time support through AI monitoring, with human assistance available when needed.

Diagnostic.ly also introduced competitive tools for independent laboratories, including AI assisted road mapping, profitability analysis, and proposal generation. These features give labs insight into their performance relative to peers and help them respond more effectively to business opportunities.